Shawn Fu

Shawn Fu, M.D. is an experienced professional in the biotech and life sciences sectors, currently serving as Vice President of Corporate Development and Head of Strategy at SonoThera since October 2022, focusing on non-viral genetic medicines. Previously held positions include Vice President at J.P. Morgan in biotech equity research, where responsibilities included large-cap biotech equity analysis, and Senior Associate at Deallus Consulting, providing strategic insights to industry leaders. Additionally, Shawn Fu has been involved as a Board Observer for multiple companies, including SpyGlass Pharma, Allay Therapeutics, and Vertex Ventures HC. Early career roles included Implementation Analyst at Epic and MCAT Instructor at Kaplan Test Prep. Educational credentials include a Doctor of Medicine degree from UT Southwestern Medical Center and a Bachelor's degree in Biology from Duke University.